Stratec SE (SBS.DE)
Stratec SE, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally.
20.00+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-25.2%
The outlook
Stratec SE currently reads as leaning bullish based on above its 50- & 200-day averages, 22% of the way from its 52-week low to high, avg target +27% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range22% of the way from its 52-week low to high
Price targetAvg target +27% vs current price
Analyst price target
~12-month · 5 analysts25.40average target+27.0% vs now
Now 20.00
Low 20.00High 37.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$243.1M
52-wk high
33.10
52-wk low
16.30
50-day avg
18.16
200-day avg
19.99
Trailing P/E
—